Archives

by in
Entry Author Date Location
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News 11/13/09 Boston
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill 11/09/09 Boston
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
E Ink Scooped up by Taiwanese Display Maker, EMC Battles NetApp For Data Domain, Polatis Picks Up $8M, & More Boston-Area Deals News 06/05/09 Boston
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News 06/03/09 Boston
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential 06/02/09 Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008… 01/05/09 Boston
Biotech Veteran Talks of Hedge Fund Investing, Boston Celtics, and Hot Companies 12/18/08 Boston
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News 10/01/08 Boston
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News 05/07/08 Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News 05/05/08 Boston
Concert Pharmaceuticals Garners $37,000,000 Series C Funding 04/30/08 Boston
Page 2 of 2 « previous page